
Cape Canaveral and Kennedy Space Center begin February launch activity following Florida's record 109 orbital launches in 2025, with seven SpaceX missions completed by end of January. Near-term schedule items include SpaceX Falcon 9 Starlink launches on Feb. 3 (Starlink 6-103, 29 satellites) and Feb. 7 (Starlink 6-104, 29 satellites) from LC-40; NASA's Artemis II no earlier than Feb. 8 from KSC Pad 39B; SpaceX Crew-12 to the ISS no earlier than Feb. 11 (6:00 a.m., sonic booms expected); and a ULA Vulcan national-security USSF-87 mission rescheduled to Feb. 12 from LC-41. Later planned flights affecting contractors and launch-service providers include Blue Origin New Glenn-3 (AST SpaceMobile payload) in late February, Blue Moon Pathfinder in H1 2026, Boeing Starliner-1 no earlier than April, and ULA/Sierra Space Dream Chaser in Q4 2026; all dates and times remain subject to change.
Market structure: The high cadence out of Cape Canaveral (109 launches in 2025) cements launch services as a near-commodity market where SpaceX retains pricing power but entrants (Blue Origin New Glenn, ULA Vulcan) create marginal downward pressure on prices (we model a 10–20% real-price erosion for generic rides over 2–3 years). Direct beneficiaries: launch vehicle suppliers, NASA/DoD prime contractors and satellite-constellation customers (ASTS is a levered beneficiary of a successful New Glenn-3). Losers: single-mission OEMs and companies whose revenue depends on flawless first flights (BA’s Starliner program carries execution risk). Risk assessment: Key tail risks are a New Glenn or Vulcan anomaly that causes a 30–60 day regulatory stand‑down (could wipe 20–50% off affected small-cap manifests) and a high‑profile Artemis/Crew anomaly that tightens NASA oversight and insurance pricing (+10–30% spike in launch insurance). Immediate (days) volatility centers on each launch window; short term (weeks–months) is dictated by post‑flight telemetry and insurance repricing; long term (quarters–years) is structural commoditization vs. differentiated government programs. Hidden dependencies: BE‑4 engine readiness, supply‑chain queueing, FCC/NTIA spectrum approvals for satcom. Trade implications: Tactical: small, event‑driven positions — prefer a 2–3% long in ASTS sized for binary outcome around New Glenn-3 (late Feb), financed via tight call spreads to cap premium; trim/avoid BA exposure (1–2% underweight) until Starliner-1 completes in-flight validation (target: within 60 days of launch). Buy 6–12 month exposure to aerospace primes with stable cash flows (LHX, RTX, NOC) at 1–3% each to play sustained NASA/DoD budgets. Options: buy directional call spreads on ASTS with expiry 90 days post-launch and protective put spreads on BA keyed to Starliner milestones. Contrarian angles: Consensus overweights SpaceX’s invulnerability and underestimates regulatory/debris risk that could slow cadence — that would temporarily reprice smaller launchers and satellite operators. Conversely, if New Glenn succeeds, ASTS (ASTS) is underpriced for carry and in-orbit service revenue; historical parallel: post‑explosion insurance repricing in 2015 created short windows to buy successful incumbents. Unintended consequence: faster cadence increases debris risk and could trigger costly mitigation rules, favoring larger contractors with compliance budgets.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment